Microchip Technology Incorporated (MCHP) Bundle
Microchip Technology Forecasts Decline in Quarterly Earnings and Revenue
Microchip Technology Incorporated (NASDAQ:MCHP) is scheduled to release its quarterly earnings report on November 6, 2025, with analyst projections indicating a year-over-year decline in key financial metrics. Wall Street consensus estimates an earnings per share (EPS) of $0.33 and revenue of approximately $1.13 billion for the quarter.
The projected EPS of $0.33 represents a significant 28.3% decrease compared to the same period last year. This projection is slightly below the company's own guidance, which forecasts EPS to be in the range of $0.34 to $0.37. In the prior quarter, Microchip reported an EPS of $0.27, which exceeded analyst expectations.
Revenue is anticipated to reach $1.13 billion, a 2.7% drop from the previous year. Despite the annual decline, Microchip's guidance for net sales is between $1.11 billion and $1.15 billion. This range suggests a potential sequential growth of 5.1%, driven by improving inventory levels and strong design wins in the industrial, aerospace, and AI sectors.
An overview of the company's financial standing shows a price-to-sales ratio of approximately 7.75 and a debt-to-equity ratio of about 0.80. The current ratio is approximately 2.31, indicating a strong ability to cover short-term liabilities. For further details, see the company's pages on its financial health and history and mission.
Microchip Technology Incorporated (MCHP) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.